Theravance Biopharma, Inc. Reports Second Quarter 2017 Financial Results and Provides Business Update

Go back to Theravance Biopharma, Inc. Reports Second Quarter 2017 Financial Results and Provides Business Update
(NASDAQ: TBPH) Delayed: 16.85 +0.29 (1.75%)
Previous Close $16.56    52 Week High $38.92 
Open $16.70    52 Week Low $12.87 
Day High $16.99    P/E N/A 
Day Low $16.64    EPS $0.00 
Volume 142,119